Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEONARDO: Plerixafor for COVID-19 Acute Respiratory Failure
NCT05411575Phase 2Withdrawn
- Sponsor
- 4Living Biotech
- Start
- Jul 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of plerixafor in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by 4Living Biotech. Planned start Jul 2022; status: withdrawn.
02
Drugs
plerixafor
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT05411575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05411575.